Elsevier

Schizophrenia Research

Volume 185, July 2017, Pages 173-181
Schizophrenia Research

Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort

https://doi.org/10.1016/j.schres.2016.12.021Get rights and content

Abstract

Objectives

Depression and negative symptoms have been associated with impaired Quality of life (QoL) in schizophrenia (SZ). However, childhood trauma may influence both QoL and depression in SZ patients, with consequences for the management of impaired QoL in SZ patients. The aim of the present study was to determine if childhood trauma was associated with impaired QoL in schizophrenia.

Method

A sample of 544 community-dwelling stabilized SZ patients enrolled in FACE-SZ cohort were utilized in this study (74.1% males, mean aged 32.3 years, mean illness duration 10.6 years). QoL was self-reported with the S-QoL18 questionnaire. Childhood trauma was self-reported with the Childhood Trauma Questionnaire. Depression was measured by the Calgary Depression Rating Scale for Schizophrenia. Psychotic severity was measured by the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). Other clinical factors, treatments, comorbidities, functioning and sociodemographical variables were also recorded, with validated scales.

Results

Overall, 151 participants (27.8%) had a current major depressive episode and 406 (82.5%) reported at least one episode of historical childhood trauma. In multivariate analyses, lower QoL total score was associated with a history of childhood trauma (β =  0.21, p < 0.0001), psychotic negative symptoms (β =  0.11, p = 0.04), current depression (β =  0.0.38, p < 0.0001) and male gender (β =  0.16, p < 0.0001).

Conclusion

Impaired QoL is independently associated with negative symptoms, depression and childhood trauma in schizophrenia.

Introduction

In 1948 the World Health Organization (WHO) defined health as not only the absence of disease, but also the presence of physical, mental and social well being (WHO, 1948). Subsequently, most branches of medicine began systematically assessing patients' subjective views of illness and symptoms, leading to the emergence of the construct of quality of life (QoL) as a promising clinical domain (Testa and Simonson, 1996). While there is still debate as to the definition of this construct and what it encompasses (Awad and Voruganti, 2012), indicators of QoL routinely include satisfaction with life/happiness (SWL), subjective evaluations of specific living conditions and objective assessments of functioning (Gladis et al., 1999).

QoL measurements are now an important aspect of the evaluation of the treatments and care provided to patients with schizophrenia (SZ) (Boyer et al., 2013a). QoL encompasses several important dimensions for patients and their families, such as psychological status, functional abilities, personal well-being, social interaction, economic status, vocational status, and physical health (Cramer et al., 2000). The use of QoL measures may provide information to clinicians regarding the general health status of their patients that might otherwise go unrecognized, thereby improving patient satisfaction and health outcomes (Boyer et al., 2013b). The knowledge of the factors that are determinants of QoL in SZ patients may assist clinicians in tailoring the most appropriate and effective interventions. However, the determinants of QoL remain poorly understood in this population.

Over recent decades, numerous studies have investigated the utility of psychotic symptoms, depression and functioning as predictors of QoL (Boyer et al., 2012, Fervaha et al., 2013, Meesters et al., 2013). Despite conflicting results due to the heterogeneity of study designs, selected characteristics, the sample examined, and the manner in which QoL has been defined and measured, general trends have emerged. A meta-analysis revealed that the strongest association was found between QoL and depression, outweighing the QoL effects of psychotic symptoms (Eack and Newhill, 2007) However, measures of functioning have been only moderately associated with QoL (Auquier et al., 2013). Importantly, six clinical predictors (including depression), explained only 20% of the QoL variance in a recent study (Fervaha et al., 2013), underscoring the need to better identify other factors that more adequately describe QoL in SZ patients.

Childhood maltreatment is a strong independent risk factor for suicidal attempts in SZ (Hassan et al., 2016), possibly aggravated by the development of depressive symptoms and feeling of hopelessness in adult life. From a biological point of view, history of childhood neglect has been found to predict disorganization in schizophrenia through grey matter decrease in dorsolateral cortex (Cancel et al., 2015). SZ patients with a history of childhood trauma may benefit from specific targeted therapies, such as cognitive behavioral therapy, which is commonly used in the management of SZ, although not always with significant efficacy in the treatment of trauma in SZ (Steel et al., 2016). It may therefore be hypothesized that history of childhood trauma may directly impact the QoL of patients with SZ. However, the association between childhood trauma and QoL in adults with SZ has not been explored to date.

The aims of the present study were (i) to determine the prevalence of a history of childhood trauma in a large non-selected multicentric sample of community-dwelling SZ patients (ii) to determine whether a history of childhood trauma was associated with impaired QoL and/or depression in adult SZ.

Section snippets

Design

The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) cohort is based on a French national network of 10 Schizophrenia Expert Centers (Bordeaux, Clermont-Ferrand, Colombes, Créteil, Grenoble, Lyon, Marseille, Montpellier, Strasbourg, Versailles), set up by a French scientific cooperation foundation, FondaMental Foundation (www.fondation-fondamental.org) and created by the French Ministry of Research in order to build a platform that links systematic clinical assessment to

Results

A sample of 544 community-dwelling stable SZ patients enrolled in FACE-SZ cohort were included in this study. Table 1 shows demographic, clinical, functioning and treatment characteristics of the sample, as well as self-reported mean QoL levels. The majority of the patients in the sample (74.1%) were men and the mean age of the patients was 32.3 ± 9.8 years. The mean age at SZ onset was 21.6 years, the mean duration of illness was 10.6 years and the mean PANSS total score was 71 ± 19. No association

Discussion

The major results of this study may be summarized as follows: in a large multi-center sample of community-dwelling SZ patients, impaired QoL was independently associated with history of childhood trauma, current major depression and negative symptoms. Current major depression had the strongest association, however childhood trauma had both a significant direct and indirect association with impaired QoL, with the indirect association mediated via depression.

The association between history of

Contributors

The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group*.

aFondation FondaMental, Créteil, France.

bCentre Hospitalier Charles Perrens, F-33076 Bordeaux, France; Université de Bordeaux ; CNRS UMR 5287-INCIA.

cHôpitaux Universitaires de Strasbourg, Université de Strasbourg, INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France

dPôle de Psychiatrie et d'addictologie des Hôpitaux Universitaires H Mondor,INSERM U955, Eq. 15 Psychiatrie Génétique

Role of funding sources

No funding.

Conflicts of interest

None declared.

References (34)

  • L. Alameda et al.

    Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome in early psychosis patients

    Psychol. Med.

    (2015)
  • P. Auquier et al.

    Toward meeting the needs of homeless people with schizophrenia: the validity of quality of life measurement

    PLoS One

    (2013)
  • A.G. Awad et al.

    Measuring quality of life in patients with schizophrenia: an update

    PharmacoEconomics

    (2012)
  • R.B. Bendel et al.

    Comparison of stopping rules in forward “stepwise” regression

    J. Am. Stat. Assoc.

    (1977)
  • F. Berna et al.

    Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.

    Schizophr. Res

    (2015)
  • L. Boyer et al.

    Measuring quality of life in patients with schizophrenia:an overview

    Expert Rev. Pharmacoecon. Outcomes Res.

    (2013)
  • Z. Bursac et al.

    Purposeful selection of variables in logistic regression

    Source Code Biol. Med.

    (2008)
  • Cited by (49)

    • Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia

      2022, Revista de Psiquiatria y Salud Mental
      Citation Excerpt :

      However, significant associations were found with physical and emotional functioning; these results are consistent with the literature, where negative symptoms and quality of life were negatively related.24 Even Andrianarisoa et al.25 found that psychotic symptoms do not have the same impact on the quality of life, where negative symptoms generated an affectation in more areas compared to positive symptoms. In spite of the different sources of ratings, we were able to demonstrate that the SNS (patient-rated) has a good discriminant validity to identify the different levels of severity rated by clinicians (CGI-SCH negative subscale).

    View all citing articles on Scopus
    View full text